---
created: 2025-04-13
updated: 2025-04-13T10:52
id: o|xuqr@*}k
specialty: gastro
specialty_id: 22
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::13-infectious-disease::06-viruses::08-antiviral-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::ribavirin
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::54-hepatitis-c-therapy
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::08-microbiology::28-antivirals
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::02-antivirals::10-hepatitis-c-therapy
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::07-antimicrobials::08-antivirals-hepatitis::ribavirin,sofosbuvir,simeprevir
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary
  - source/ak-step1-v11::^systems::gi::pharm"
type: flashcard
---

# Question
Ribavirin must be **phosphorylated three times::specific** by intracellular enzymes to reach its activated nucleotide form

---

# Answer
once active, ribavirin inhibits RNA production